AOD-9604 vs 5-Amino-1MQ

AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (amino acids 176-191) of human growth hormone, with an added tyrosine residue. Preclinical research has documented its lipolytic activity independent of the broader GH-IGF-1 axis, with selective effects on fat metabolism and no measurable impact on glucose homeostasis or IGF-1 levels. This selectivity makes it a focused research tool for adipocyte biology. 5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that consumes methyl donors and depletes cellular NAD+ pools. By inhibiting NNMT, 5-Amino-1MQ preserves NAD+ availability and shifts adipocyte metabolism toward energy expenditure. Preclinical studies have examined its role in metabolic regulation, fat cell differentiation, and NAD+ salvage pathways.

AOD-9604

Compound Class Peptide (GH fragment)
Primary Mechanism Direct lipolytic activity
Research Focus Adipocyte lipolysis, body composition
IGF-1 Effect None in preclinical models
Administration Format Reconstituted lyophilized peptide
Key Targets HSL, beta-3 adrenergic pathway

5-Amino-1MQ

Compound Class Small molecule (NNMT inhibitor)
Primary Mechanism NNMT inhibition, NAD+ preservation
Research Focus Metabolic regulation, NAD+ biology
IGF-1 Effect None reported
Administration Format Oral capsules or reconstituted
Key Targets NNMT enzyme, NAD+ salvage cycle

The Verdict

AOD-9604 and 5-Amino-1MQ both appear in metabolic research but operate through fundamentally different mechanisms. AOD-9604 directly stimulates lipolysis without engaging the broader GH axis, making it useful for studying isolated fat metabolism pathways. 5-Amino-1MQ targets NAD+ availability through NNMT inhibition, addressing metabolic regulation at the cellular energy level. The two are complementary research tools for investigators studying different layers of adipocyte and metabolic biology.

AOD-9604 vs 5-Amino-1MQ — FAQ

Are these compounds chemically related?
No. AOD-9604 is a peptide derived from growth hormone, while 5-Amino-1MQ is a small molecule enzyme inhibitor. They share no structural similarity but both appear in metabolic research.
Why does AOD-9604 not affect IGF-1?
AOD-9604 retains only the lipolytic signaling fragment of growth hormone and lacks the structural domains responsible for GH receptor binding and IGF-1 stimulation.
What is NNMT and why is it relevant?
NNMT (nicotinamide N-methyltransferase) is an enzyme that consumes nicotinamide and S-adenosylmethionine, depleting NAD+ precursors. Inhibiting NNMT preserves NAD+ availability for cellular energy metabolism.
Can they be combined in research?
Their mechanisms are non-overlapping, so combined protocols are possible. However, most research isolates one mechanism at a time to avoid confounding variables.

References

Primary sources for key clinical and regulatory claims on this page.

  1. A new anti-obesity compound, AOD9604, reduces body weight in obese Zucker rats by stimulating lipolysis — PubMed / Int J Obes Relat Metab Disord . Primary preclinical source for AOD-9604 lipolytic activity without GH axis engagement.
  2. Targeting NNMT for metabolic dysfunction — PubMed / Trends Pharmacol Sci . Review of NNMT inhibition as a metabolic research target including 5-Amino-1MQ activity.

Keep Researching

Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.

Research Peptides Category
Updated March 2026. This comparison is reviewed for catalog accuracy, sourcing language, and consistency with our public quality standards. It is an educational summary for research reference only. Read our Editorial Standards.

Ready to order?

Pick your product and check out in under 3 minutes.

Shop Now